Skip to content
knowrare
HealthSignal
Your condition community

Living with Familial chronic myelocytic leukemia-like syndrome

A rare inherited blood cancer that starts in early infancy and lacks the usual Philadelphia chromosome.

Understanding Familial chronic myelocytic leukemia-like syndrome

Familial chronic myelocytic leukemia-like syndrome is a chronic myeloid leukemia that starts in early infancy.

It does not have the BCR/ABL fusion gene (the Philadelphia chromosome), which is found in typical chronic myeloid leukemia.

Signs & symptoms

GARD doesn't list specific symptoms for this condition yet.

Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.

Diagnosis

  1. Talk with your doctor

    Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.

  2. See a specialist

    Your doctor may refer you to a specialist who knows rare conditions.

  3. Ask which tests can help

    Your care team will decide which exams and tests can confirm the diagnosis.

Care & treatment

Care team
A doctor familiar with rare conditions, plus specialists as needed
Expert care
Ask about multidisciplinary care centers for rare conditions
Treatment
GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
Research
Clinical trials and observational studies may be options. See the research section below.

General information, not medical advice. Your care team makes the decisions.

Everyday life

Living with a rare condition is easier with support.

  • Connect with rare disease patient organizations for support
  • Keep notes on symptoms, changes and questions for appointments
  • Ask about patient registries that help research
  • Look into financial aid and travel resources for care visits
Bring these questions to your next doctor visit
What tests confirm this diagnosis?
What treatment options are available for an infant?
Which specialists should be on my child's care team?

Quick facts

InheritanceAutosomal Dominant

This condition is autosomal dominant, which means a change in one copy of the gene can cause it. GARD does not name the gene.

Also known as: cml-like syndrome, familial; familial cml-like syndrome

Patient organizations

Rare-disease groups that can help

Source: NIH GARD · Familial chronic myelocytic leukemia-like syndromeGARD ID 10141 · GARD page updated September 2026 · Plain-language summary by Know Rare; editorial review pending. General information, not medical advice.

You are more than your diagnosis

Perspectives from people navigating life with Familial chronic myelocytic leukemia-like syndrome.

Explore the Familial chronic myelocytic leukemia-like syndrome blog

Explore research for Familial chronic myelocytic leukemia-like syndrome

Explore actively recruiting Familial chronic myelocytic leukemia-like syndrome studies with HealthSpark.

HealthSpark

Find actively recruiting studies for Familial chronic myelocytic leukemia-like syndrome with HealthSpark. Share your city to explore research near you.

  • Recruiting studies from ClinicalTrials.gov
  • Share your city to look for research near you
  • Eligibility is confirmed by the study team

Powered by HealthSpark, our AI chat helper

I can help you find recruiting Familial chronic myelocytic leukemia-like syndrome studies. Enter a ZIP code, address or city below and I'll look within 50 miles.

Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.

Get Signals for Familial chronic myelocytic leukemia-like syndrome

Stay in the loop with community stories and updates from medical researchers.

HealthStoryfor Familial chronic myelocytic leukemia-like syndrome

Create a living journal that talks back

HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your Familial chronic myelocytic leukemia-like syndrome experiences more deeply and prepare for better conversations with your doctors and care team.

Start your journal

Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.